This statement, dated 29 February 2024, is made available pursuant to Article 2a of the Decree on the Content of the Directors' Report (Besluit inhoud bestuursverslag, hereafter the "Decree") that requires Dutch businesses to publish a statement on their approach to corporate governance and their compliance with the Dutch Corporate Governance Code (hereafter the "Code").1
The information referred to in Article 3 to 3b of the Decree can be found in the following sections of IMCD's 2023 Integrated Annual Report2 (hereafter the "Annual Report"):
Information on:
AR section reference / title
AR page
reference
➢ compliance with the provisions and best practice
•
Chapter 12. Corporate Governance
97
principles of the Code3 and any motivated deviation
•
Paragraph 12.11 Accountability Code
106
thereof
➢ the most important characteristics of the risk
•
Chapter 13. Risk factors and risk
107
management and control systems in connection with
management
IMCD's financial reporting process
➢ the functioning of the IMCD's General Meeting of
•
Paragraph 12.6. Shareholders and
104
Shareholder and its main powers, the rights of
their rights
IMCD's shareholders and how they can be exercised
➢ the composition and functioning of the Management
•
Paragraph 12.2 Management Board
97
Board
➢ the composition and functioning of the Supervisory
•
Paragraph 12.4 Supervisory Board
102
Board and its committees
•
Chapter 10. Supervisory Board report
76
➢ IMCD's D&I Policy, including goals for the
•
Chapter 4. People & Culture value
48
composition of the Management Board, Supervisory
•
Paragraph 12.5. Diversity on the
104
Board, Executive Committee and Sub-top, plans to
Supervisory Board, Management
achieve such goals and results of the policy in the
Board, Executive Committee
past year
•
Note 2.2 (Diversity, Equity & Inclusion)
130
to the Sustainability Statements
Insofar as applicable, and to the extent relevant, the information referred to in the Decree implementing Article 10 of the Takeover Directive can be found in the following sections of the Annual Report:
Information on:
AR section reference / title
AR page
reference
➢ the capital structure, the (non-)existence of different
•
Chapter 8. Information on the IMCD
71
types of shares and the associated rights and
Share
obligations and the percentage of the issued capital
•
Paragraph 12.6 Shareholders and
104
represented by each type
their rights
•
Note 46 (Shareholders' equity) to the
270
financial statements
This statement is published electronically and available for download in theCorporate Governance sectionon IMCD's website.
As published on March 1st, 2024, and available for download in the Reports & presentations sectionon IMCD's website.
As published at www.commissiecorporategovernance.nl.
➢ any restriction on the transfer of shares or share
•
Paragraph 12.6 Shareholders and
104
certificates issued with the cooperation of the
their rights
company
➢ limitation on voting rights, terms for the exercise of
•
Paragraph 12.6 Shareholders and
104
voting rights and the issuance, with the cooperation of
their rights
the company, of depositary receipts for shares
➢ the rules for appointing and replacing members of the
•
Paragraph 12.2 Management Board
97
Management Board and Supervisory Board
•
Paragraph 12.4 Supervisory Board
102
➢ the rules for amending the Company's articles of
•
Paragraph 12.6. Shareholders and
104
association
their rights
➢ the powers of the management board to issue or
•
Paragraph 12.6. Shareholders and
104
repurchase shares in IMCD
their rights
Attachments
Original Link
Original Document
Permalink
Disclaimer
IMCD NV published this content on
29 February 2024 and is solely responsible for the information contained therein. Distributed by
Public, unedited and unaltered, on
01 March 2024 11:12:46 UTC.
IMCD N.V. is one of the world's leaders in the distribution of specialty chemicals and food ingredients. The group's activity is organized primarily around 8 markets:
- house cleaning and maintenance products and textile products: surfactants, abrasives, bleaching agents, dyes, solubilizing agents, functional additives, etc.;
- pharmaceutical products: excipients, active pharmaceutical ingredients, solvents, formulation intermediates and chemical synthesis, etc.;
- personal care products: dyes, rheology modifiers, active and functional and sensory ingredients, sunscreen agents, antioxidants, exfoliants, preservatives, etc.;
- coating products: additives, pigments, resins and special solvents;
- nutritional and food products: acids, emulsifiers, oils, fibers, preservatives, sweeteners, enzymes, plant extracts, etc.;
- lubricants: additives, silicone derivatives, esters, corrosion inhibitors, markers, surfactants, etc.;
- chemical products synthesis: monomers, catalysts, reactive diluents, solvents and additives;
- plastic products: mixers, thermoplastic elastomers, polyurethanes, composite materials, etc.
Net sales break down geographically as follows: the Netherlands (1.5%), Europe/Middle East/Africa (42.2%), Asia/Pacific (24.5%), North America (22.3%), and Latin America (9.5%).